Julie Foster

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial

Daniela Manno, Agnes Bangura, Frank Baiden et al. · The Lancet Infectious Diseases · 2022 · 25 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

E Choi, Boris Lacarra, Muhammed O. Afolabi et al. · The Lancet Global Health · 2023 · 17 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Identification of an antigenic subtype of eastern equine encephalitis virus isolated from a human

Charles H. Calisher, Nick Karabatsos, Julie Foster et al. · Journal of Clinical Microbiology · 1990 · 11 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17